Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE By knocking out STAT3 specifically in mouse β-cells, we found that the loss of STAT3 sensitized mice to three low doses of STZ stimulation resulting in hyperglycemia. 31097787 2020
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Macroencapsulated Human iPSC-Derived Pancreatic Progenitors Protect against STZ-Induced Hyperglycemia in Mice. 30853374 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE The study revealed the ability of GK-2 to ameliorate hyperglycemia induced by streptozotocine (STZ 100 mg/kg i.p.) in C57Bl/6 mice, to restore learning ability in the Morris Water Maze test, and to overcome depression after both intraperitoneal (0.5 mg/kg) and peroral (5 mg/kg) long-term administration. 28740732 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE To induce T2D, mice were fed normal diet (ND) or high fat diet (HFD) for 3 months to induce insulin resistance, followed by an intraperitoneal injection of STZ to induce hyperglycemia. 30876865 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Our analysis indicated that G-Rk3 reduced HFD/STZ induced hyperglycemia, and serum insulin and inflammation levels, and ameliorated glucose tolerance and insulin resistance, and prevented liver histological changes. 30993294 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE The crude extract, chloroform, and ethyl acetate fractions were more potent in controlling the hyperglycemia in STZ-induced type 2 diabetes in rats and considerable reduction of glucose level was observed compared to the non-treated group. 30545352 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE <i>Ephx2</i> depletion had no detectable effects on STZ-induced hyperglycemia but prevented the development of tear deficiency. 29615440 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE IL-33 given simultaneously with the application of STZ completely prevented the development of hyperglycemia, glycosuria and profoundly attenuated mononuclear cell infiltration. 30498495 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE In conclusion, we demonstrated that NCRAE, a natural extract of chicory (Cichorium intybus) rich in CRA and CQAs improves glucose tolerance and reduces the basal hyperglycemia in STZ diabetic rats. 29325917 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE This study demonstrates that STZ-induced diabetic female mice exhibit a heightened susceptibility to diastolic dysfunction, despite exhibiting a lower extent of hyperglycemia than male mice. 29402990 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Diosmin lowered hyperglycaemia in a dose-dependent manner in STZ-diabetic rats. 28218955 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Exercise prevented fasting hyperglycemia in the Ex STZ group. 27447720 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE It was shown that symptoms of diabetes (hyperglycemia, bodyweight loss, damaged hepatocyte ultrastructure), signs of oxidative stress in liver (2-fold intensification of peroxide process and 2-fold depletion of antioxidants) and serum markers of liver damage (3.5-, 1.5- and 5-fold increase in levels of ALT, AST and GGT, respectively) were present in STZ-diabetic rats. 29132096 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Findings from the current study consent us to conclude that menthol alleviates STZ-NA-induced hyperglycemia via modulating glucose metabolizing enzymes, suppression of pancreatic β-cells apoptosis and altered hepatic, pancreatic morphology. 28549291 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Correction of hyperglycemia in STZ mice also decreased the hepatic hepassocin expression. 28402540 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE The increased MOR in the hearts of STZ rats was reversed by the reduction of hyperglycemia. 28577871 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Cichoric acid improved hyperglycaemia and restored muscle injury via activating antioxidant response in MLD-STZ-induced diabetic mice. 28655651 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE In STZ-injected rats, we found that hyperglycemia dramatically increased the levels of PTEN and PTEN-Ser380/Thr382/383 phosphorylation, reduced both levels of p-eNOS and p-Akt, and disrupted BBB function assayed by Evans blue staining, which were abolished by SQ29548 treatment. 28415790 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Renal EPOR expression was reduced by insulin and phloridzin in STZ rats, and hyperglycemia recovered. 29174036 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE For in vivo studies, WT and Akt<sup>-/-</sup> mice were fed a normal diet containing RSV (400 mg·kg<sup>-1</sup>·d<sup>-1</sup>) for 2 weeks, then followed by injection of STZ to induce hyperglycemia (300 mg/dL). 27941804 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE As the results, AAV2-PG succeeded to improve the hyperglycemia of STZ-induced diabetic humanized liver mice. 27545600 2016
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE We report the correction of hyperglycemia of STZ induced diabetic mice using one intravenous systemic administration of a single stranded serotype 8 pseudotyped adeno-associated virus (ssAAV2/8) vector encoding the human proinsulin gene under a constitutive liver specific promoter. 26795016 2016
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE The cells were also found to ameliorate hyperglycaemia in STZ (streptozotocin) induced diabetic NOD/SCID (non-obese diabetic/severe combined immunodeficiency) mouse up to 96 days of transplantation. 22897387 2012